施贵宝(BMY)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

BMY 施贵宝

已收盘 12-11 16:00:00 EST

51.20

-0.01

-0.02%

盘后51.32

+0.12+0.23%

19:46 EST

最高51.48	最低50.44	成交量968.43万
今开51.11	昨收51.21	日振幅2.03%
总市值1,042亿	流通市值1,040亿	总股本20.36亿
成交额4.95亿	换手率0.48%	流通股本20.32亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"BMY","market":"US","secType":"STK","nameCN":"施贵宝","latestPrice":51.2,"timestamp":1765486800000,"preClose":51.21,"halted":0,"volume":9684297,"hourTrading":{"tag":"盘后","latestPrice":51.32,"preClose":51.2,"latestTime":"19:46 EST","volume":404278,"amount":20699278.2112,"timestamp":1765500377580},"delay":0,"floatShares":2031646263,"shares":2035753027,"eps":2.970486,"marketStatus":"已收盘","change":-0.01,"latestTime":"12-11 16:00:00 EST","open":51.11,"high":51.48,"low":50.44,"amount":494734030.24437,"amplitude":0.020309,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":2.970486,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1765530000000},"marketStatusCode":5,"adr":0,"adrRate":0,"listingDate":-18475200000,"exchange":"NYSE","adjPreClose":51.21,"dividendRate":0.04841,"preHourTrading":{"tag":"盘前","latestPrice":51.14,"preClose":51.21,"latestTime":"09:29 EST","volume":2793,"amount":143703.39711,"timestamp":1765463371082},"postHourTrading":{"tag":"盘后","latestPrice":51.32,"preClose":51.2,"latestTime":"19:46 EST","volume":404278,"amount":20699278.2112,"timestamp":1765500377580},"volumeRatio":0.634892,"impliedVol":0.2799,"impliedVolPercentile":0.128},"requestUrl":"/m/hq/s/BMY/wiki","defaultTab":"wiki","newsList":[{"id":"1172575849","title":"美国食品药品监督管理局（FDA）对施贵宝Opdivo®（Nivolumab）联合化疗治疗经典型霍奇金淋巴瘤的申请给予优先审评","url":"https://stock-news.laohu8.com/highlight/detail?id=1172575849","media":"美股速递","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1172575849?lang=zh_cn&edition=full","pubTime":"2025-12-11 19:59","pubTimestamp":1765454366,"startTime":"0","endTime":"0","summary":"美国食品药品监督管理局（FDA）对施贵宝Opdivo®（Nivolumab）联合化疗治疗经典型霍奇金淋巴瘤的申请给予优先审评。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0225771236.USD","LU0306807586.USD","BK4559","LU1261432733.SGD","LU2242652126.USD","BK4588","LU1093756168.USD","LU1430594728.SGD","LU2242646821.SGD","LU2125154778.USD","LU0868494617.USD","LU1291159041.SGD","IE00B2B36J28.USD","LU0267386448.USD","IE00BFXG1179.USD","LU0114720955.EUR","IE00BSNM7G36.USD","LU1989771016.USD","LU2133065610.SGD","LU1323610961.USD","BK4007","BK4581","BK4585","IE0002141913.USD","BK4534","LU0882574055.USD","IE0009355771.USD","LU1585245621.USD","LU1868836591.USD","LU1868837136.USD","IE00BJJMRZ35.SGD","LU1670710661.SGD","LU1718418525.SGD","LU0096364046.USD","LU1571399168.USD","LU1868836914.USD","LU0237698245.USD","LU1093756325.SGD","IE00BJT1NW94.SGD","LU1670710588.SGD","LU0061475181.USD","LU1868836757.USD","LU0321505868.SGD","LU0456855351.SGD","LU0225284248.USD","BK4532","LU0985481810.HKD","IE00BFTCPJ56.SGD","LU1032466523.USD","LU1074936037.SGD","LU2360032135.SGD","LU1670711040.USD","LU1868837300.USD","LU2125154935.USD","LU1670711123.USD","LU0321505439.SGD","BMY","LU0306806265.USD"],"gpt_icon":0},{"id":"2590231598","title":"富国银行上调施贵宝目标价至55美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2590231598","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590231598?lang=zh_cn&edition=full","pubTime":"2025-12-11 15:47","pubTimestamp":1765439222,"startTime":"0","endTime":"0","summary":"富国银行将施贵宝的目标价从53美元上调至55美元，维持“持有”评级。(格隆汇)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushizhibo/20251211/31859114.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BMY"],"gpt_icon":0},{"id":"1103967501","title":"Biontech与施贵宝公布Pumitamig全球二期研究数据","url":"https://stock-news.laohu8.com/highlight/detail?id=1103967501","media":"投资观察","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1103967501?lang=zh_cn&edition=full","pubTime":"2025-12-09 20:18","pubTimestamp":1765282713,"startTime":"0","endTime":"0","summary":"12月9日（路透社）- BioNTech SE与施贵宝首次公布PD-L1XVEGF-A双特异性抗体Pumitamig在晚期三阴性乳腺癌中的全球二期研究数据，显示出令人鼓舞的疗效。Pumitamig联合化疗实现了61.5%的确认客观反应率、71.8%的未确认客观反应率和92.3%的疾病控制率，与PD-L1表达水平无关。这些数据与先前在中国进行的1L TNBC I期/II期临床试验中报告的数据一致，并确认了关键III期ROSETTA BREAST-01试验的剂量选择。相关数据将于2025年圣安东尼奥乳腺癌研讨会上公布。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BJJMRZ35.SGD","LU1571399168.USD","BK4585","LU1989771016.USD","LU0114720955.EUR","BK4551","BK4559","BK4535","BMY","IE00BFTCPJ56.SGD","BK4007","LU1323610961.USD","LU0306806265.USD","LU1670711040.USD","LU0306807586.USD","LU0882574055.USD","IE00B2B36J28.USD","LU0096364046.USD","LU2125154778.USD","BNTX","BK4139","IE00BFXG1179.USD","LU0321505439.SGD","LU1430594728.SGD","IE00BSNM7G36.USD","LU0321505868.SGD","LU1074936037.SGD","LU1093756168.USD","BK4532","LU1261432733.SGD","LU1670710661.SGD","LU0237698245.USD","LU1868837300.USD","LU1585245621.USD","LU2242652126.USD","IE0009355771.USD","LU2125154935.USD","LU2360032135.SGD","IE00BJT1NW94.SGD","LU0225771236.USD","LU2242646821.SGD","LU0225284248.USD","IE0002141913.USD","LU0456855351.SGD","LU0868494617.USD","LU1032466523.USD","LU0267386448.USD","LU0985481810.HKD","LU1868836914.USD","LU1670711123.USD","LU0061475181.USD","LU1868836591.USD","BK4568","BK4548","BK4534","BK4588","LU1868836757.USD","LU1718418525.SGD","BK4581","LU2133065610.SGD","LU1868837136.USD","LU1291159041.SGD","LU1670710588.SGD","LU1093756325.SGD"],"gpt_icon":0},{"id":"1117454392","title":"BioNTech Se：Pumitamig联合化疗在所有四种化疗方案中的安全性均可控","url":"https://stock-news.laohu8.com/highlight/detail?id=1117454392","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1117454392?lang=zh_cn&edition=full","pubTime":"2025-12-09 20:04","pubTimestamp":1765281849,"startTime":"0","endTime":"0","summary":"BioNTech Se：Pumitamig联合化疗在所有四种化疗方案中均展现出可管理的安全性特征，且在两个队列中均表现良好。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1093756168.USD","LU2360032135.SGD","LU1585245621.USD","LU1670710661.SGD","LU2125154778.USD","LU2242652126.USD","LU1291159041.SGD","IE00B2B36J28.USD","IE00BSNM7G36.USD","LU0321505439.SGD","LU1323610961.USD","LU1989771016.USD","LU0868494617.USD","LU0985481810.HKD","LU0321505868.SGD","BK4534","LU1670711123.USD","BK4532","LU0456855351.SGD","LU0882574055.USD","LU0225771236.USD","BK4585","BK4559","LU1718418525.SGD","LU1868837300.USD","BK4588","LU2242646821.SGD","IE00BFTCPJ56.SGD","LU0096364046.USD","LU0114720955.EUR","LU1868837136.USD","LU1571399168.USD","LU1670711040.USD","LU1670710588.SGD","IE0002141913.USD","LU0237698245.USD","LU0267386448.USD","IE00BJJMRZ35.SGD","LU0306807586.USD","BMY","LU1093756325.SGD","LU0306806265.USD","BK4007","LU1868836914.USD","IE00BJT1NW94.SGD","LU0061475181.USD","LU1868836757.USD","LU2125154935.USD","LU1261432733.SGD","LU0225284248.USD","IE00BFXG1179.USD","LU1074936037.SGD","LU1032466523.USD","LU1430594728.SGD","LU1868836591.USD","LU2133065610.SGD","IE0009355771.USD","BK4581"],"gpt_icon":0},{"id":"2588040563","title":"美股异动 | 百时美施贵宝(BMY.US)涨5% 公司将继续阿尔茨海默病研究","url":"https://stock-news.laohu8.com/highlight/detail?id=2588040563","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588040563?lang=zh_cn&edition=full","pubTime":"2025-12-03 23:30","pubTimestamp":1764775808,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，周三，百时美施贵宝(BMY.US)涨5%，报50.67美元。消息面上，施贵宝周三表示，将招募更多参与者参加一项晚期试验，以评估Cobenfy治疗阿尔茨海默病痴呆相关精神病的安全性和有效性。该公司表示，在发现少数试验地点与临床研究执行相关的“不规范行为”后作出此决定，这些地点的患者数据将从主要分析中排除。据了解，Cobenfy目前已获批用于治疗成人精神分裂症，具有成为首个基于毒蕈碱受体激动作用、针对躁动和精神病的新一类药物疗法的潜力。预计ADEPT计划(包括ADEPT-2、ADEPT-1和ADEPT-4)针对阿尔茨海默病相关精神病的其他试验结果将在2026年底揭晓。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1377514.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU1261432733.SGD","BK4585","BK4532","LU0456855351.SGD","LU0096364046.USD","LU1868836757.USD","IE00BJT1NW94.SGD","BK4559","IE0002141913.USD","LU2125154935.USD","IE00BJJMRZ35.SGD","LU1585245621.USD","BK4588","LU0306806265.USD","LU0321505439.SGD","LU2242646821.SGD","IE00B2B36J28.USD","BMY","LU1868837136.USD","LU0868494617.USD","LU0985481810.HKD","LU2133065610.SGD","LU1670711040.USD","LU1074936037.SGD","LU2360032135.SGD","LU0061475181.USD","LU1868836591.USD","LU1571399168.USD","LU1291159041.SGD","LU1670710661.SGD","IE0009355771.USD","LU1718418525.SGD","LU0225771236.USD","IE00BSNM7G36.USD","LU1868836914.USD","LU0114720955.EUR","LU1093756325.SGD","LU0267386448.USD","LU1093756168.USD","LU1670710588.SGD","IE00BFXG1179.USD","LU1323610961.USD","LU1430594728.SGD","BK4581","LU0321505868.SGD","LU0882574055.USD","LU1989771016.USD","LU0225284248.USD","BK4534","LU2125154778.USD"],"gpt_icon":0},{"id":"1145973221","title":"施贵宝股价在盘前上涨3.4%，继续招募阿尔茨海默病药物试验患者","url":"https://stock-news.laohu8.com/highlight/detail?id=1145973221","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1145973221?lang=zh_cn&edition=full","pubTime":"2025-12-03 21:26","pubTimestamp":1764768379,"startTime":"0","endTime":"0","summary":"施贵宝股价在盘前上涨3.4%，继续招募阿尔茨海默病药物试验患者","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BFXG1179.USD","LU0267386448.USD","LU1670711040.USD","LU0061475181.USD","LU1430594728.SGD","LU0225771236.USD","LU0985481810.HKD","IE00BFTCPJ56.SGD","LU0306806265.USD","LU0868494617.USD","LU1670710661.SGD","LU1718418525.SGD","BK4007","LU0237698245.USD","LU1074936037.SGD","LU2125154778.USD","BK4532","LU0321505868.SGD","BK4534","LU1670710588.SGD","LU1670711123.USD","LU1868836757.USD","LU1585245621.USD","LU1571399168.USD","LU0321505439.SGD","IE00B2B36J28.USD","BK4585","LU1323610961.USD","BK4581","LU1868836591.USD","LU2133065610.SGD","BMY","LU1261432733.SGD","BK4588","LU2242652126.USD","LU2242646821.SGD","LU1989771016.USD","IE00BSNM7G36.USD","LU0225284248.USD","LU0882574055.USD","LU1093756325.SGD","IE0002141913.USD","LU0456855351.SGD","LU2360032135.SGD","LU1868836914.USD","IE00BJT1NW94.SGD","IE0009355771.USD","LU2125154935.USD","LU1291159041.SGD","IE00BJJMRZ35.SGD","LU0114720955.EUR","LU1093756168.USD","LU1032466523.USD","LU1868837300.USD","LU0306807586.USD","LU0096364046.USD","LU1868837136.USD","BK4559"],"gpt_icon":0},{"id":"2588046192","title":"百时美施贵宝将继续推进阿尔茨海默病药物三期临床研究","url":"https://stock-news.laohu8.com/highlight/detail?id=2588046192","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588046192?lang=zh_cn&edition=full","pubTime":"2025-12-03 20:59","pubTimestamp":1764766777,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["LU1868836591.USD","IE0002141913.USD","IE0009355771.USD","LU1670711123.USD","LU1868836757.USD","IE00B2B36J28.USD","LU1074936037.SGD","LU0267386448.USD","BK4581","BK4585","LU0114720955.EUR","LU2125154778.USD","BK4532","LU1430594728.SGD","LU0225771236.USD","LU0321505868.SGD","LU2360032135.SGD","LU1323610961.USD","LU2242652126.USD","LU1670710661.SGD","BMY","LU2242646821.SGD","LU0985481810.HKD","LU1670710588.SGD","LU1093756168.USD","LU2125154935.USD","LU0882574055.USD","LU1571399168.USD","LU1261432733.SGD","LU1868836914.USD","LU0456855351.SGD","LU1868837300.USD","IE00BJT1NW94.SGD","LU0306806265.USD","LU1032466523.USD","LU1868837136.USD","IE00BJJMRZ35.SGD","IE00BSNM7G36.USD","LU0868494617.USD","BK4534","BK4007","LU2133065610.SGD","LU1291159041.SGD","LU1989771016.USD","BK4588","LU1585245621.USD","LU0061475181.USD","LU1093756325.SGD","IE00BFXG1179.USD","LU0237698245.USD"],"gpt_icon":0},{"id":"1186291513","title":"施贵宝宣布继续进行针对阿尔茨海默病相关精神病的Adept-2三期研究","url":"https://stock-news.laohu8.com/highlight/detail?id=1186291513","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1186291513?lang=zh_cn&edition=full","pubTime":"2025-12-03 19:59","pubTimestamp":1764763170,"startTime":"0","endTime":"0","summary":"施贵宝宣布继续进行针对阿尔茨海默病相关精神病的Adept-2三期研究","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0306807586.USD","LU1868837300.USD","LU0868494617.USD","LU0321505439.SGD","IE00B2B36J28.USD","BK4585","LU1261432733.SGD","LU1323610961.USD","LU1868836591.USD","LU2125154778.USD","LU0225284248.USD","LU1093756168.USD","LU1670711123.USD","LU1989771016.USD","IE00BJJMRZ35.SGD","LU0321505868.SGD","LU0096364046.USD","LU1868836914.USD","LU0114720955.EUR","BK4532","LU0985481810.HKD","LU0882574055.USD","LU0225771236.USD","IE0002141913.USD","LU1571399168.USD","LU1718418525.SGD","LU1291159041.SGD","BK4581","IE00BFXG1179.USD","BK4559","LU1093756325.SGD","BK4588","LU0237698245.USD","IE00BJT1NW94.SGD","LU1868836757.USD","LU0061475181.USD","LU0267386448.USD","IE00BFTCPJ56.SGD","LU1430594728.SGD","LU1585245621.USD","LU1670710661.SGD","LU1670710588.SGD","LU2125154935.USD","LU2242652126.USD","LU2133065610.SGD","LU2242646821.SGD","LU0306806265.USD","LU1670711040.USD","LU1074936037.SGD","LU1868837136.USD","IE0009355771.USD","IE00BSNM7G36.USD","LU1032466523.USD","BK4007","BMY","LU0456855351.SGD","BK4534","LU2360032135.SGD"],"gpt_icon":0},{"id":"1187354797","title":"施贵宝CEO Boerner：施贵宝预计在英美制药交易后未来5年将能够投资超过5亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1187354797","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1187354797?lang=zh_cn&edition=full","pubTime":"2025-12-01 22:56","pubTimestamp":1764600985,"startTime":"0","endTime":"0","summary":"施贵宝CEO Boerner表示，施贵宝预计在英美制药交易后，未来5年将能够投资超过5亿美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BFTCPJ56.SGD","LU0225771236.USD","IE0002141913.USD","BK4532","IE00BFXG1179.USD","BK4007","LU0306807586.USD","LU1074936037.SGD","LU2242646821.SGD","IE00B2B36J28.USD","LU1291159041.SGD","LU0267386448.USD","IE00BJT1NW94.SGD","BK4534","LU1585245621.USD","LU1718418525.SGD","LU1868836757.USD","LU0456855351.SGD","LU0321505868.SGD","BK4559","LU2133065610.SGD","BK4585","LU1868836914.USD","LU2242652126.USD","LU1571399168.USD","LU2360032135.SGD","BK4588","LU2125154935.USD","LU0061475181.USD","LU0114720955.EUR","LU0306806265.USD","IE0009355771.USD","LU1093756168.USD","LU1868837136.USD","LU1670710661.SGD","LU1670710588.SGD","BK4581","LU0882574055.USD","LU1032466523.USD","LU1323610961.USD","LU0237698245.USD","LU0985481810.HKD","LU1868836591.USD","LU2125154778.USD","IE00BSNM7G36.USD","LU0868494617.USD","BMY","LU0321505439.SGD","IE00BJJMRZ35.SGD","LU1670711040.USD","LU0225284248.USD","LU1670711123.USD","LU0096364046.USD","LU1093756325.SGD","LU1868837300.USD","LU1261432733.SGD","LU1989771016.USD","LU1430594728.SGD"],"gpt_icon":0},{"id":"1154511184","title":"施贵宝在2025年ASH大会上展示血液学管线潜力，推动下一代产品组合的动能","url":"https://stock-news.laohu8.com/highlight/detail?id=1154511184","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1154511184?lang=zh_cn&edition=full","pubTime":"2025-12-01 20:00","pubTimestamp":1764590411,"startTime":"0","endTime":"0","summary":"施贵宝在2025年ASH大会上展示血液学管线潜力，推动下一代产品组合的动能","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1074936037.SGD","LU1032466523.USD","LU0456855351.SGD","LU1093756168.USD","BK4534","LU0321505439.SGD","LU1670711040.USD","LU1323610961.USD","IE0002141913.USD","LU0306807586.USD","LU1868836914.USD","LU0267386448.USD","BMY","BK4559","LU1571399168.USD","LU1868837136.USD","LU2360032135.SGD","LU0114720955.EUR","LU0868494617.USD","LU0882574055.USD","IE00BFXG1179.USD","LU1430594728.SGD","LU1261432733.SGD","LU1093756325.SGD","LU0321505868.SGD","LU1868836757.USD","LU2242646821.SGD","LU2125154778.USD","IE0009355771.USD","LU0225771236.USD","BK4585","BK4588","LU1291159041.SGD","BK4007","LU1670710661.SGD","LU1989771016.USD","LU0096364046.USD","LU0061475181.USD","LU0985481810.HKD","IE00BJT1NW94.SGD","LU1868836591.USD","LU0237698245.USD","LU0225284248.USD","IE00BFTCPJ56.SGD","LU1670710588.SGD","LU2242652126.USD","LU1670711123.USD","BK4581","LU1718418525.SGD","BK4532","LU1585245621.USD","LU2125154935.USD","LU2133065610.SGD","IE00B2B36J28.USD","IE00BSNM7G36.USD","LU1868837300.USD","IE00BJJMRZ35.SGD","LU0306806265.USD"],"gpt_icon":0},{"id":"1197403315","title":"四川百利天恒表示仍有资格获得高达2.5亿美元的短期付款，以及在达到特定研发、监管、商业里程碑后获得高达71亿美元的额外付款","url":"https://stock-news.laohu8.com/highlight/detail?id=1197403315","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1197403315?lang=zh_cn&edition=full","pubTime":"2025-11-30 17:18","pubTimestamp":1764494292,"startTime":"0","endTime":"0","summary":"四川百利天恒表示仍有资格获得高达2.5亿美元的短期付款，以及在达到特定研发、监管、商业里程碑后获得高达71亿美元的额外付款。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BJJMRZ35.SGD","LU1571399168.USD","BK4585","LU1989771016.USD","LU0114720955.EUR","BK0239","BK4559","BMY","IE00BFTCPJ56.SGD","LU1323610961.USD","BK4007","LU0306806265.USD","LU1670711040.USD","LU0306807586.USD","LU0882574055.USD","IE00B2B36J28.USD","LU0096364046.USD","LU2125154778.USD","IE00BFXG1179.USD","LU0321505439.SGD","LU1430594728.SGD","IE00BSNM7G36.USD","LU0321505868.SGD","LU1074936037.SGD","LU1093756168.USD","BK4532","LU1261432733.SGD","LU1670710661.SGD","LU0237698245.USD","LU1868837300.USD","LU1585245621.USD","LU2242652126.USD","IE0009355771.USD","LU2125154935.USD","LU2360032135.SGD","IE00BJT1NW94.SGD","LU0225771236.USD","LU2242646821.SGD","LU0225284248.USD","IE0002141913.USD","LU0456855351.SGD","LU0868494617.USD","LU1032466523.USD","LU0267386448.USD","LU0985481810.HKD","688506","LU1868836914.USD","LU1670711123.USD","LU0061475181.USD","LU1868836591.USD","BK4588","BK4534","LU1868836757.USD","LU1718418525.SGD","BK4581","LU2133065610.SGD","LU1868837136.USD","LU1291159041.SGD","LU1670710588.SGD","LU1093756325.SGD"],"gpt_icon":0},{"id":"1112180261","title":"百利天恒宣布其子公司近期已从施贵宝获得2.5亿美元里程碑付款，涉及Iza-Bren全球战略协议","url":"https://stock-news.laohu8.com/highlight/detail?id=1112180261","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1112180261?lang=zh_cn&edition=full","pubTime":"2025-11-30 17:18","pubTimestamp":1764494292,"startTime":"0","endTime":"0","summary":"百利天恒宣布其子公司近期已从施贵宝获得2.5亿美元的里程碑付款，涉及Iza-Bren全球战略协议。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4559","LU1093756325.SGD","LU1868836591.USD","IE0002141913.USD","IE0009355771.USD","LU1670711123.USD","LU1868836757.USD","LU0306807586.USD","LU1670711040.USD","IE00B2B36J28.USD","LU1074936037.SGD","LU0267386448.USD","BK4585","BK4581","LU0114720955.EUR","LU2125154778.USD","LU0225284248.USD","688506","BK4532","LU1430594728.SGD","LU0225771236.USD","LU0321505868.SGD","LU2360032135.SGD","LU1323610961.USD","LU2242652126.USD","LU1670710661.SGD","BMY","LU2242646821.SGD","LU0985481810.HKD","LU1670710588.SGD","LU1093756168.USD","LU2125154935.USD","LU0882574055.USD","LU1571399168.USD","LU1261432733.SGD","BK0239","LU0456855351.SGD","LU1868836914.USD","LU1868837300.USD","IE00BJT1NW94.SGD","LU0306806265.USD","LU1032466523.USD","LU1868837136.USD","LU0096364046.USD","IE00BJJMRZ35.SGD","IE00BSNM7G36.USD","LU0868494617.USD","LU1718418525.SGD","BK4534","BK4007","LU0321505439.SGD","LU2133065610.SGD","LU1291159041.SGD","LU1989771016.USD","BK4588","LU1585245621.USD","LU0061475181.USD","IE00BFTCPJ56.SGD","IE00BFXG1179.USD","LU0237698245.USD"],"gpt_icon":0},{"id":"2587799680","title":"百利天恒(688506.SH)子公司收到与百时美施贵宝就iza-bren项目里程碑付款2.5亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2587799680","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2587799680?lang=zh_cn&edition=full","pubTime":"2025-11-30 16:56","pubTimestamp":1764492983,"startTime":"0","endTime":"0","summary":"智通财经APP讯，百利天恒(688506.SH)发布公告，公司全资子公司SystImmune近期收到由BMS支付的2.5亿美元里程碑付款。根据合作协议，公司后续还有资格获得最高可达2.5亿美元的近期或有付款，以及在达到特定的开发、注册和销售里程碑后最高可达71亿美元的额外付款。合作协议中所约定的里程碑付款需要满足一定的条件，最终里程碑付款尚存在不确定性。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1375666.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU0321505439.SGD","LU0096364046.USD","LU1670711123.USD","IE00BSNM7G36.USD","LU1430594728.SGD","IE0002141913.USD","LU2133065610.SGD","BK4532","BK4007","BK4588","BMY","LU0306807586.USD","IE00BFTCPJ56.SGD","LU2360032135.SGD","LU1093756325.SGD","LU1323610961.USD","LU1868837136.USD","BK4581","LU0882574055.USD","IE00BJT1NW94.SGD","LU2242652126.USD","LU1291159041.SGD","LU0225771236.USD","LU1093756168.USD","LU1670710588.SGD","LU0985481810.HKD","LU1074936037.SGD","LU1868836914.USD","LU1585245621.USD","LU1261432733.SGD","LU1868836757.USD","LU1032466523.USD","91194","IE00BJJMRZ35.SGD","BK4585","LU0114720955.EUR","02615","LU0267386448.USD","LU1670710661.SGD","LU1718418525.SGD","LU2125154935.USD","LU0306806265.USD","BK0239","LU1868837300.USD","IE00B2B36J28.USD","688506","LU2242646821.SGD","LU0868494617.USD","LU1868836591.USD","BK4559"],"gpt_icon":0},{"id":"1135447751","title":"施贵宝获得欧盟委员会批准，扩大Breyanzi在复发或难治性套细胞淋巴瘤中的应用","url":"https://stock-news.laohu8.com/highlight/detail?id=1135447751","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1135447751?lang=zh_cn&edition=full","pubTime":"2025-11-25 06:00","pubTimestamp":1764021612,"startTime":"0","endTime":"0","summary":"施贵宝获得欧盟委员会批准，扩大Breyanzi在复发或难治性套细胞淋巴瘤中的应用","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0456855351.SGD","LU1670710661.SGD","LU2360032135.SGD","LU0882574055.USD","LU0267386448.USD","LU2242652126.USD","LU1032466523.USD","LU0868494617.USD","LU1291159041.SGD","BK4007","IE00BFXG1179.USD","IE00B2B36J28.USD","LU0321505868.SGD","LU1868836914.USD","BMY","LU1868836757.USD","LU1868837300.USD","LU1670711123.USD","LU1670711040.USD","LU1261432733.SGD","IE00BJJMRZ35.SGD","BK4588","LU0225284248.USD","LU1323610961.USD","BK4534","LU0321505439.SGD","LU1430594728.SGD","LU1585245621.USD","LU2133065610.SGD","LU2125154935.USD","LU1571399168.USD","BK4532","LU1989771016.USD","LU0237698245.USD","LU0114720955.EUR","LU2125154778.USD","LU2242646821.SGD","BK4585","IE00BJT1NW94.SGD","LU1074936037.SGD","LU0225771236.USD","LU1718418525.SGD","LU0096364046.USD","LU0985481810.HKD","LU1670710588.SGD","LU1093756168.USD","LU1093756325.SGD","BK4559","LU0061475181.USD","LU1868836591.USD","LU0306806265.USD","BK4581","IE00BSNM7G36.USD","IE0002141913.USD","IE0009355771.USD","IE00BFTCPJ56.SGD","LU1868837136.USD","LU0306807586.USD"],"gpt_icon":0},{"id":"1111753231","title":"施贵宝股价在盘前交易中上涨4.2%，因拜耳公布心血管药物的积极晚期数据","url":"https://stock-news.laohu8.com/highlight/detail?id=1111753231","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1111753231?lang=zh_cn&edition=full","pubTime":"2025-11-24 18:22","pubTimestamp":1763979738,"startTime":"0","endTime":"0","summary":"施贵宝股价在盘前交易中上涨4.2%，因拜耳公布心血管药物的积极晚期数据。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1093756168.USD","IE0002141913.USD","LU1868836591.USD","LU0306807586.USD","LU0225771236.USD","LU1868836757.USD","LU0096364046.USD","IE00B2B36J28.USD","LU1074936037.SGD","IE00BJT1NW94.SGD","IE00BJJMRZ35.SGD","LU1718418525.SGD","BK4585","LU2360032135.SGD","IE00BFXG1179.USD","LU1670711040.USD","LU1670710661.SGD","BK4007","LU0237698245.USD","BK4534","IE00BFTCPJ56.SGD","LU1571399168.USD","LU0985481810.HKD","LU0456855351.SGD","LU1323610961.USD","LU1670710588.SGD","LU0306806265.USD","BK4588","LU1261432733.SGD","LU1868837136.USD","LU1291159041.SGD","LU0061475181.USD","LU0868494617.USD","LU1032466523.USD","LU0267386448.USD","LU0321505868.SGD","LU1670711123.USD","LU2242646821.SGD","IE0009355771.USD","BK4532","LU0225284248.USD","LU0321505439.SGD","BK4559","LU1585245621.USD","LU2133065610.SGD","IE00BSNM7G36.USD","LU2242652126.USD","LU1093756325.SGD","LU1989771016.USD","LU1868837300.USD","LU2125154778.USD","BK4581","LU0114720955.EUR","LU2125154935.USD","BMY","LU0882574055.USD","LU1868836914.USD","LU1430594728.SGD"],"gpt_icon":0},{"id":"1195547184","title":"德克萨斯州检察长起诉施贵宝和赛诺菲，指控未披露Plavix对部分患者效果不佳","url":"https://stock-news.laohu8.com/highlight/detail?id=1195547184","media":"美股速递","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1195547184?lang=zh_cn&edition=full","pubTime":"2025-11-21 04:52","pubTimestamp":1763671939,"startTime":"0","endTime":"0","summary":"德克萨斯州检察长起诉施贵宝和赛诺菲，指控未披露Plavix对部分患者效果不佳","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BMY","LU1074936037.SGD","LU1430594728.SGD","LU1670711123.USD","BK4588","IE0002141913.USD","BK4559","LU0114720955.EUR","LU1571399168.USD","LU2125154935.USD","LU0306806265.USD","LU1989771016.USD","LU1868836914.USD","LU0225284248.USD","LU0225771236.USD","BK4581","LU1032466523.USD","LU0882574055.USD","LU0061475181.USD","LU1585245621.USD","LU1868837300.USD","LU0096364046.USD","LU2133065610.SGD","LU1093756168.USD","LU1718418525.SGD","LU2125154778.USD","BK4534","LU0306807586.USD","BK4532","LU0267386448.USD","IE00BJT1NW94.SGD","LU0456855351.SGD","LU1291159041.SGD","LU1868837136.USD","IE00B2B36J28.USD","LU1670711040.USD","LU0868494617.USD","LU1261432733.SGD","IE00BFXG1179.USD","IE00BFTCPJ56.SGD","LU1323610961.USD","LU0321505439.SGD","LU0985481810.HKD","LU1670710588.SGD","LU2242652126.USD","BK4007","LU1670710661.SGD","LU0237698245.USD","LU1093756325.SGD","IE0009355771.USD","IE00BSNM7G36.USD","LU0321505868.SGD","LU1868836757.USD","IE00BJJMRZ35.SGD","LU2360032135.SGD","LU2242646821.SGD","BK4585","LU1868836591.USD"],"gpt_icon":0},{"id":"1161533720","title":"关于Phase 3 Librexia ACS试验的最新进展","url":"https://stock-news.laohu8.com/highlight/detail?id=1161533720","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1161533720?lang=zh_cn&edition=full","pubTime":"2025-11-20 01:49","pubTimestamp":1763574550,"startTime":"0","endTime":"0","summary":"11月14日 - 施贵宝公司：*关于Phase 3 Librexia ACS试验的最新进展*施贵宝公司 - 由于疗效问题，Librexia ACS试验已被终止*施贵宝公司 - 对Milvexian未发现新的安全性问题*施贵宝公司 - Librexia AF和中风研究仍在继续，数据预计将在2026年发布","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE0002141913.USD","IE00BFTCPJ56.SGD","LU1571399168.USD","LU1670711123.USD","IE00BJT1NW94.SGD","LU1868836914.USD","LU0321505439.SGD","LU1868836757.USD","IE0009355771.USD","BK4559","LU1261432733.SGD","LU2242646821.SGD","LU0306807586.USD","LU1670710588.SGD","LU1868837300.USD","LU0114720955.EUR","LU0225771236.USD","IE00B2B36J28.USD","LU0985481810.HKD","LU0456855351.SGD","LU2360032135.SGD","BK4007","LU0882574055.USD","LU0061475181.USD","LU1868837136.USD","LU1868836591.USD","LU1585245621.USD","IE00BFXG1179.USD","BK4581","LU0225284248.USD","LU0868494617.USD","LU1093756168.USD","LU0267386448.USD","BK4588","LU1670711040.USD","LU1074936037.SGD","LU1093756325.SGD","LU1323610961.USD","LU0096364046.USD","LU1670710661.SGD","LU1718418525.SGD","LU0237698245.USD","LU2133065610.SGD","LU2242652126.USD","BK4585","LU2125154935.USD","IE00BSNM7G36.USD","LU0306806265.USD","LU2125154778.USD","LU1989771016.USD","BK4534","IE00BJJMRZ35.SGD","LU1032466523.USD","LU0321505868.SGD","LU1430594728.SGD","BK4532","BMY","LU1291159041.SGD"],"gpt_icon":0},{"id":"1121818488","title":"Evotec获得施贵宝500万美元的里程碑付款","url":"https://stock-news.laohu8.com/highlight/detail?id=1121818488","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1121818488?lang=zh_cn&edition=full","pubTime":"2025-11-20 01:27","pubTimestamp":1763573254,"startTime":"0","endTime":"0","summary":"11月12日（路透社）- Evotec SE：*EVOTEC SE - 在与施贵宝的战略合作伙伴关系中，因IND申请获得批准，收到里程碑付款。*EVOTEC SE - 此药物候选剂是在该合作中开发的，预计将在2026年开始进行I期临床试验。*EVOTEC SE - IND申请的FDA批准触发了对EVOTEC的500万美元里程碑付款。*进一步公司的相关信息：EVTG.DE*","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1868836757.USD","IE00BFXG1179.USD","LU2360032135.SGD","LU1670710588.SGD","IE00BJT1NW94.SGD","LU0225771236.USD","LU1323610961.USD","LU2125154935.USD","LU1868837136.USD","IE00BSNM7G36.USD","LU1430594728.SGD","LU1585245621.USD","LU0306806265.USD","BK4581","BK4532","LU0267386448.USD","LU1670711040.USD","BK4585","LU1093756325.SGD","LU1670710661.SGD","LU0061475181.USD","LU1718418525.SGD","IE00BFTCPJ56.SGD","LU1868836914.USD","LU0096364046.USD","IE00B2B36J28.USD","LU0321505439.SGD","LU1868837300.USD","LU2242652126.USD","BK4588","LU0456855351.SGD","IE00BJJMRZ35.SGD","LU1093756168.USD","LU1868836591.USD","LU0985481810.HKD","BK4559","LU1571399168.USD","LU0237698245.USD","LU0225284248.USD","LU2133065610.SGD","IE0002141913.USD","LU1032466523.USD","LU1291159041.SGD","LU0306807586.USD","LU0868494617.USD","LU1074936037.SGD","LU1989771016.USD","BK4534","LU2242646821.SGD","LU2125154778.USD","LU1670711123.USD","BMY","LU0114720955.EUR","LU1261432733.SGD","LU0321505868.SGD","LU0882574055.USD","IE0009355771.USD","BK4007"],"gpt_icon":0},{"id":"1123559588","title":"施贵宝宣布优先参与结果、收购要约修订及提前结算","url":"https://stock-news.laohu8.com/highlight/detail?id=1123559588","media":"美股速递","labels":["merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1123559588?lang=zh_cn&edition=full","pubTime":"2025-11-18 11:33","pubTimestamp":1763436792,"startTime":"0","endTime":"0","summary":"施贵宝宣布优先参与结果、收购要约修订及提前结算","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0306806265.USD","LU0321505868.SGD","LU1261432733.SGD","LU1670711040.USD","LU1868836591.USD","LU2125154935.USD","LU0456855351.SGD","LU0237698245.USD","BK4007","LU0321505439.SGD","LU2242652126.USD","BK4559","LU0096364046.USD","LU1718418525.SGD","LU1989771016.USD","IE00BFTCPJ56.SGD","LU0985481810.HKD","IE00BJJMRZ35.SGD","LU1323610961.USD","BK4585","BMY","LU0882574055.USD","LU1032466523.USD","LU1670710588.SGD","LU1868836914.USD","LU2360032135.SGD","LU0225771236.USD","IE00BJT1NW94.SGD","BK4588","LU1093756325.SGD","LU1430594728.SGD","LU0114720955.EUR","LU0306807586.USD","LU1585245621.USD","LU1670711123.USD","IE0009355771.USD","LU1868837136.USD","LU0225284248.USD","BK4581","LU1291159041.SGD","IE0002141913.USD","IE00B2B36J28.USD","LU2125154778.USD","LU2133065610.SGD","LU1868837300.USD","LU1571399168.USD","LU1868836757.USD","BK4532","LU1093756168.USD","LU0267386448.USD","LU1670710661.SGD","LU1074936037.SGD","LU2242646821.SGD","IE00BFXG1179.USD","IE00BSNM7G36.USD","LU0061475181.USD","BK4534","LU0868494617.USD"],"gpt_icon":0},{"id":"1155821555","title":"施贵宝股价盘前下跌5.4%，因公司与强生暂停心脏药物试验","url":"https://stock-news.laohu8.com/highlight/detail?id=1155821555","media":"美股速递","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1155821555?lang=zh_cn&edition=full","pubTime":"2025-11-14 21:11","pubTimestamp":1763125882,"startTime":"0","endTime":"0","summary":"施贵宝股价盘前下跌5.4%，因公司与强生在中期评估后暂停了心脏药物试验。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0234572021.USD","LU1066051225.USD","LU0058720904.USD","LU0792757196.USD","LU2430703251.USD","LU0432979614.USD","LU0234570918.USD","LU2430703178.SGD","LU2750360997.AUD","LU1221951046.USD","LU1430594728.SGD","LU1894683348.USD","LU2089984988.USD","LU1868837300.USD","LU2242646821.SGD","LU2471134796.USD","LU0306806265.USD","BK4550","SG9999002232.USD","IE00BVYPNV92.GBP","LU0985481810.HKD","LU1059921491.USD","IE00BJJMRZ35.SGD","IE00BBT3K403.USD","LU0203347892.USD","BK4585","IE00BSNM7G36.USD","LU1196500208.SGD","LU2129689605.HKD","LU0237698245.USD","BK4534","IE00B4R5TH58.HKD","BK4504","IE00BDGV0183.EUR","BMY","IE00BLSP4452.SGD","BK4581","LU2592432038.USD","LU1929549753.HKD","LU0795875169.SGD","LU0985320562.USD","LU1670710588.SGD","LU0321505439.SGD","LU2129689431.USD","IE00BLSP4239.USD","LU2133065610.SGD","LU2471134952.CNY","LU0345770308.USD","LU0345769631.USD","LU1506573853.SGD","JNJ","LU2129689514.USD","LU1221951129.SGD","LU0061475181.USD","LU0098860793.USD","LU1732799900.SGD","LU1914381329.SGD","LU0640476718.USD","LU1261432733.SGD","IE00B19Z3B42.SGD","BK4592","LU0345770993.USD","LU1989771016.USD","LU0114720955.EUR","LU1023059063.AUD","LU1061106388.HKD","IE00B19Z3581.USD","LU1093756325.SGD","IE0034235303.USD","LU1674673691.USD","LU1935042991.SGD","IE00BN8TJ469.HKD","BK4532","LU0306807586.USD","LU2505996681.GBP","IE00BVYPNW00.USD","LU1066051498.USD","LU1670710661.SGD","IE00B1BXHZ80.USD","IE00BJT1NW94.SGD","LU1674673428.USD","LU0225284248.USD","LU1093756168.USD","LU1291159041.SGD","LU2347655156.SGD","BK4588","LU1162221912.USD","LU0868494617.USD","LU2242652126.USD","LU0225771236.USD","LU0267386448.USD","IE000M9KFDE8.USD","LU1066053197.SGD","LU1032466523.USD","LU0882574055.USD","IE00BFXG1179.USD","LU0122379950.USD","LU1585245621.USD","LU0912757837.SGD","LU1894683264.USD","IE00B2B36J28.USD","IE00B42XCP33.USD","LU2112291526.USD","LU1066051811.HKD","LU0321505868.SGD","LU0466842654.USD","LU2602419157.SGD","LU2125154778.USD","LU2125154935.USD","LU1074936037.SGD","LU1267930813.SGD","LU1778281490.HKD","LU0289739699.SGD","LU0320765646.SGD","LU1244550494.USD","LU2468319806.SGD","SG9999001440.SGD","LU1323610961.USD","LU1670711040.USD","LU2471134879.HKD","LU1496350502.SGD","LU0795875086.SGD","IE00BFTCPJ56.SGD","LU0345769128.USD","LU2360032135.SGD","LU1868836757.USD","IE0002141913.USD","LU0096364046.USD","LU1244550221.USD","LU1868836914.USD","LU2430703095.HKD","LU1571399168.USD","LU1244550577.SGD","LU2471134523.USD","LU1032955483.USD","LU0456855351.SGD","LU1280957306.USD","BK4533","LU2505996509.AUD","BK4007","BK4568","IE0002270589.USD","BK4559","LU1732800096.USD","SG9999002224.SGD","LU0203345920.USD","LU1718418525.SGD","IE0009355771.USD","LU0070217475.USD","LU2750360641.GBP","IE00B7SZLL34.SGD","LU1057294990.SGD","LU0889566641.SGD","LU1670711123.USD","IE00BGHQF631.EUR","IE00B3PB1722.GBP","LU1868836591.USD","LU1868837136.USD","IE00B3T34201.USD"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.bms.com","stockEarnings":[{"period":"1week","weight":0.0049},{"period":"1month","weight":0.0836},{"period":"3month","weight":0.0772},{"period":"6month","weight":0.0293},{"period":"1year","weight":-0.1189},{"period":"ytd","weight":-0.0946}],"compareEarnings":[{"period":"1week","weight":0.0054},{"period":"1month","weight":0.009},{"period":"3month","weight":0.0455},{"period":"6month","weight":0.1517},{"period":"1year","weight":0.1406},{"period":"ytd","weight":0.1732}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"百时美施贵宝公司于1933年8月根据特拉华州法律注册成立，名为百时美公司，继承了1887年在纽约成立的一家企业。1989年，由于合并，公司更名为百时美施贵宝公司。该公司在全球范围内从事生物制药产品的发现、开发、许可、制造、营销、分销和销售。该公司预计，对Celgene和MyoKardia的收购将进一步将公司定位为领先的生物制药公司，通过几项近期资产和额外的外部合作伙伴关系扩大其肿瘤学、血液学、免疫学和心血管领域的投资组合。","yearOnYearQuotes":[{"month":1,"riseRate":0.466667,"avgChangeRate":-0.012031},{"month":2,"riseRate":0.555556,"avgChangeRate":0.009164},{"month":3,"riseRate":0.644444,"avgChangeRate":0.008753},{"month":4,"riseRate":0.478261,"avgChangeRate":-0.005913},{"month":5,"riseRate":0.565217,"avgChangeRate":0.002647},{"month":6,"riseRate":0.608696,"avgChangeRate":0.009417},{"month":7,"riseRate":0.413043,"avgChangeRate":-0.001733},{"month":8,"riseRate":0.521739,"avgChangeRate":-0.001022},{"month":9,"riseRate":0.521739,"avgChangeRate":0.00993},{"month":10,"riseRate":0.586957,"avgChangeRate":0.025121},{"month":11,"riseRate":0.630435,"avgChangeRate":0.022318},{"month":12,"riseRate":0.630435,"avgChangeRate":0.021059}],"exchange":"NYSE","name":"施贵宝","nameEN":"Bristol-Myers Squibb"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.11","shortVersion":"4.35.11","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"施贵宝(BMY)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供施贵宝(BMY)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"施贵宝,BMY,施贵宝股票,施贵宝股票老虎,施贵宝股票老虎国际,施贵宝行情,施贵宝股票行情,施贵宝股价,施贵宝股市,施贵宝股票价格,施贵宝股票交易,施贵宝股票购买,施贵宝股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"施贵宝(BMY)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供施贵宝(BMY)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}